batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Bayer still waiting on Vividion 4 April 2025 AACR 2025 preview – China dares to be different 3 April 2025 Merck KGaA’s Inspirna bet goes south 1 April 2025 Surprise win for Corcept's glucocorticoid therapy 31 March 2025 Enhertu targets HER2-positive lung again 31 March 2025 German Merck makes SpringWorks holders squirm 28 March 2025 Another Sanofi setback for Innate 27 March 2025 ELCC 2025 – AstraZeneca gets a survival boost from Laura 25 March 2025 Load More